Understanding effect site pharmacology of uprifosbuvir, a HCV nucleoside inhibitor: case study of a multidisciplinary modelling approach in drug development
2020 ◽
Vol 31
(1)
◽
pp. 1
2021 ◽
Vol 21
(1)
◽
pp. 279-299
Keyword(s):
Keyword(s):
2021 ◽
pp. 151-172
Keyword(s):